Positive and negative effects of perampanel treatment on psychiatric and behavioral symptoms in adult patients with epilepsy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Positive and negative effects of perampanel treatment on psychiatric and behavioral symptoms in adult patients with epilepsy
Authors
Keywords
Antiepileptic drugs, Perampanel, Psychiatric adverse events, Psychiatric and behavioral comorbidities, Periictal psychiatric symptoms, Carbamazepine
Journal
EPILEPSY & BEHAVIOR
Volume -, Issue -, Pages 107515
Publisher
Elsevier BV
Online
2021-02-18
DOI
10.1016/j.yebeh.2020.107515
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Perampanel effect on sleep architecture in patients with epilepsy
- (2020) Rodrigo Rocamora et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- The Relationship Between Epilepsy and Anxiety Disorders
- (2019) Coraline Hingray et al. Current Psychiatry Reports
- Transient Epileptic Amnesia: A Treatable Cause of Spells Associated With Persistent Cognitive Symptoms
- (2019) Vijay K Ramanan et al. Frontiers in Neurology
- Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites
- (2019) Chun Yang et al. Translational Psychiatry
- A History of the Pharmacological Treatment of Bipolar Disorder
- (2018) Francisco López-Muñoz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs: Focus on Topiramate, Levetiracetam, and Perampanel
- (2018) Cerine C. Hansen et al. BEHAVIOURAL NEUROLOGY
- Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy
- (2017) Baibing Chen et al. EPILEPSY & BEHAVIOR
- Psychiatric comorbidities in epilepsy: Should they be considered in the classification of epileptic disorders?
- (2016) Andres M. Kanner EPILEPSY & BEHAVIOR
- Sleep quality and daytime sleepiness in patients treated with adjunctive perampanel for focal seizures
- (2016) Manuel Toledo et al. EPILEPSY & BEHAVIOR
- Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action
- (2015) Jesper T Andreasen et al. BRAIN RESEARCH
- Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanel
- (2015) Alan B. Ettinger et al. EPILEPSIA
- Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy
- (2015) Jacqueline A. French et al. NEUROLOGY
- Ictal and Peri-Ictal Psychopathology
- (2014) Marco Mula et al. BEHAVIOURAL NEUROLOGY
- Adverse effects and safety profile of perampanel: A review of pooled data
- (2014) Fergus Rugg-Gunn EPILEPSIA
- Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: Results from phase III extension study 307
- (2014) Gregory L. Krauss et al. EPILEPSIA
- The clinical pharmacology profile of the new antiepileptic drug perampanel: A novel noncompetitive AMPA receptor antagonist
- (2014) Philip N. Patsalos EPILEPSIA
- Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist
- (2013) M. A. Rogawski et al. ACTA NEUROLOGICA SCANDINAVICA
- Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: A pooled analysis of three phase III studies
- (2013) Bernhard J. Steinhoff et al. EPILEPSIA
- Premature mortality in epilepsy and the role of psychiatric comorbidity: a total population study
- (2013) Seena Fazel et al. LANCET
- Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: Interim results from phase III, extension study 307
- (2012) Gregory L. Krauss et al. EPILEPSIA
- Interictal dysphoric disorder and periictal dysphoric symptoms in patients with epilepsy
- (2010) Marco Mula et al. EPILEPSIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started